SOURCE: Huifeng Bio-Pharmaceutical Technology, Inc.

July 13, 2007 09:49 ET

Huifeng CEO to Give Live Interview on MN1.com

XI'AN, CHINA--(Marketwire - July 13, 2007) - Huifeng Bio-Pharmaceutical (OTCBB: HFGB) is pleased to announce that its CEO, Jing'An Wang, will be featured in a live interview with Market News First, an online news broadcast and research group featuring the latest opportunities within the micro cap market.

The interview is scheduled for Tuesday, July 17, 2007, at 9:00 AM EDT and will be broadcast live from Market News First's website found at www.mn1.com. This is an exciting opportunity for Mr. Wang to discuss the company's unique services, so be sure to tune in and listen to Mr. Wang talk about the company's progress and plans for the future.

About Huifeng Bio-Pharmaceutical Technology, Inc.

Huifeng Bio-Pharmaceutical Technology, Inc. located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related, plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations.

About MN1.com

Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live IPTV web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies' present condition and future plans.

Stay up to date with MN1 NewsWire "News You Can Trust" at http://www.mn1.com.

Contact Information